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Research
A wide range of environmental chemicals 
can interfere with androgen production and 
signaling and have been shown to alter the 
development of the male reproductive tract 
in experimental animals (Foster 2006; Gray 
et al. 2006). Establishing links between anti-
androgenic exposure in utero and similar out-
comes in humans is challenging, however, in 
part because the genital anomalies traditionally 
examined in humans (e.g., hypospadias) occur 
with such a low incidence that studying them 
requires very large populations. Thus, a more 
sensitive (and continuous) meas  ure of the 
develop  mental androgenic milieu is desirable.
Anogenital distance (AGD; distance from 
anus to genitals) may serve as such a meas  ure. 
AGD is routinely used in animal toxicology 
studies and is the developmental end point 
most sensitive to anti  androgenic exposure. In 
rodents and other mammals, AGD has been 
shown to reflect the amount of androgen to 
which a male fetus is exposed in early devel-
opment; higher in utero androgen exposure 
results in longer and more masculine AGD. 
Recent interest in reproductive effects of anti-
androgens has focused on the phthalates, 
particularly diethylhexyl phthalate (DEHP) 
and dibutyl phthalate (DBP), whose anti-
androgenic effects have been directly demon-
strated in rodent models (Gray et al. 2006; 
Scott et al. 2008). We previously reported 
strong inverse associations between pre  natal 
phthalate exposure (particularly DEHP and 
DBP) and shorter male AGD in human 
infants (Swan 2008; Swan et al. 2005). 
In many rodent studies, shortened AGD is 
seen in conjunction with frank defects such as 
hypospadias and cryptorchidism, and shorter 
AGD has been seen in conjunction with 
hypospadias in human males (Hsieh et al. 
2008). Moreover, in male rodents, shortened 
(weight-adjusted) AGD persists into adult-
hood (Hotchkiss et al. 2004) and predicts 
compromised reproductive function in the 
mature male (Macleod et al. 2010; Scott et al. 
2008). However, to our knowledge, no study 
has examined associations between AGD in 
adults and sperm number or quality.
Definitively demonstrating that AGD 
provides a link between prenatal anti  androgen 
exposure and adult reproductive function in 
humans would require the availability of bio-
logical samples reflecting pre  natal exposure 
and subsequent follow-up across the many 
years between exposure and sexual matura-
tion. However, associations between AGD 
and adult reproductive function in humans 
would provide indirect evidence.
In this study, we explored the hypothe  sis 
that AGD may be a predictor of semen quality 
in adult humans. If confirmed, this biomarker 
may provide information about the androgenic 
hormonal milieu during fetal development and 
may be useful in studies of reproductive devel-
opment and function in adulthood.
Materials and Methods
Study population. Subjects were participants in 
the Rochester Young Men’s Study (RYMS), a 
cross-sectional study of young men conducted 
in 2009–2010 at the University of Rochester 
(Rochester, NY). RYMS is part of an interna-
tional study funded by the European Union 
Seventh Framework Program (Environment), 
“Developmental Effects of Environment on 
Reproductive Health” (DEER). Men were 
recruited into RYMS through flyers and news-
papers at college and university campuses 
in the Rochester area. Subjects were eligible 
if they were born in the United States after 
31 December 1987, able to read and speak 
English, and able to contact their mother 
and ask her to complete a questionnaire. In 
response to advertisements placed at local col-
leges, a total of 389 potential participants con-
tacted our study coordinator between spring 
2009 and spring 2010. Of these, 305 (78.4%) 
met all eligibility criteria, and 222 men par-
ticipated in the study. AGD measurements 
were obtained only for men who enrolled 
September 2009 and later. One man with a 
history of testicular cancer was azospermic 
(sperm count of 0) and was not included in 
analysis. Motility data were excluded for one 
man whose time to semen analysis exceeded 
30 min. The analysis reported here includes all 
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Ba c k g r o u n d: In male rodents, anogenital distance (AGD) provides a sensitive and continuous 
correlate of androgen exposure in the intra  uterine environment and predicts later reproductive suc-
cess. Some endocrine-disrupting chemicals can alter male reproductive tract development, including 
shortening AGD, in both rodents and humans. Whether AGD is related to semen quality in human 
is unknown.
oB j e c t i v e: We examined associations between AGD and semen parameters in adult males.
Me t h o d s : We used multiple regression analyses to model the relationships between sperm param-
eters and two alternative measures of AGD [from the anus to the posterior base of the scrotum 
(AGDAS) and to the cephalad insertion of the penis (AGDAP)] in 126 volunteers in Rochester, 
New York.
re s u l t s: AGDAS, but not AGDAP, was associated with sperm concentration, motility, morphol-
ogy, total sperm count, and total motile count (p-values, 0.002–0.048). Men with AGDAS below 
(vs. above) the median were 7.3 times more likely (95% confidence interval, 2.5–21.6) to have a low 
sperm concentration (< 20 × 106/mL). For a typical study participant, sperm concentrations were 
34.7 × 106/mL and 51.6 × 106/mL at the 25th and 75th percentiles of (adjusted) AGDAS.
co n c l u s i o n s: In our population, AGDAS was a strong correlate of all semen parameters and a pre-
dictor of low sperm concentration. In animals, male AGD at birth reflects androgen levels during 
the masculinization programming window and predicts adult AGD and reproductive function. Our 
results suggest, therefore, that the androgenic environment during early fetal life exerts a fundamen-
tal influence on both AGD and adult sperm counts in humans, as demonstrated in rodents.
key w o r d s : anogenital distance, anti  androgens, endocrine disruption, semen quality, testicular   
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126 men with complete data on all study out-
comes and covariates, including both meas-
ures of AGD, except sperm morphology data, 
which was available for only 124 men.
The study included a physical examina-
tion; blood, urine, and semen samples; and 
completion of a brief questionnaire. Subjects 
received $75 upon completion of all study 
components. Data from the mother’s ques-
tionnaire were not considered in this analysis. 
The University of Rochester Research Subjects 
Review Board approved the study, and written 
informed consent was obtained from all sub-
jects before their participation.
Semen collection and analysis. Men col-
lected semen samples by masturbation at the 
clinic and were asked to report the time of 
their previous ejaculation. Although they were 
asked to abstain from ejaculation for at least 
48 hr before sample collection, they were not 
excluded if they had not. Abstinence times 
reported to be > 240 hr (n = 3) were trun-
cated at 240 hr. Sample processing was initi-
ated within 30 min of collection. Ejaculate 
volumes were estimated by specimen weight, 
assuming a semen density of 1.0 g/mL. Sperm 
concentration was evaluated by hemo  cytometer 
(Improved Neubauer; Hauser Scientific Inc., 
Horsham, PA, USA). Two chambers of the 
hemo  cytometer were counted, and the aver-
age was used in this analysis. Motility was 
analyzed using World Health Organization 
(WHO 1999) criteria; the percentage of all 
sperm that were classified as forward motile 
(“A + B,” where highly or moderately progres-
sive sperm are scored as “A” and slow or slug-
gish progressive sperm are scored as “B”) were 
used in all analyses and considered motile in 
this analysis. We also calculated the total sperm 
count (volume × sperm concentration) and the 
total motile count (volume × sperm concentra-
tion × percent motile). Smears for morphol-
ogy were made, air-dried, fixed, and shipped 
to the University Department of Growth 
and Reproduction at the Rigshospitalet 
(Copenhagen, Denmark). The slides were 
Papanicolaou stained and assessed using strict 
criteria (Menkveld et al. 1990). To increase 
consistency and comparability of methods over 
the course of the study, six sets of duplicate 
semen samples were sent during the study from 
the University of Copenhagen’s Department of 
Growth and Reproduction to the Andrology 
Laboratory (University of Rochester), 
which is Clinical Laboratory Improvement 
Amendments certified. 
Physical examination. A physical exami-
nation of each participant was performed, and 
weight and height assessed, on the same day as 
semen, urine, and blood sampling. The pres-
ence of varicocele or other abnormalities were 
noted, and testicular size was estimated using 
Prader’s orchidometer (Andrology Australia, 
Clayton, Victoria, Australia).
In this study we measured two variants 
of AGD: The first was measured from the 
cephalad insertion of the penis to the center 
of the anus (AGDAP; Figure 1, point 1 to 
point 3), and the second was measured from 
the posterior base (first fold) of the scrotum 
to the center of the anus (AGDAS; Figure 1, 
point 2 to point 3). Both were measured 
using a stainless-steel digital caliper (VWR 
International, LLC, West Chester, PA, USA) 
and made while the man was in the lithotomy 
position, with his thighs at a 45° angle to the 
examination table. To improve precision, the 
examiner made each of these measurements 
twice, and the mean of the two measurements 
(within-observer mean) was used as the esti-
mate. (More detailed instructions for con-
ducting this exam and an anatomically correct 
figure demonstrating landmarks are available 
upon request.)
A single examiner (J.M.) conducted most 
of the exams (94%), and a second (J. Stevens) 
examined the remaining seven men. Both 
examiners independently examined eight 
of these men in three sessions conducted 
throughout the collection period. Neither the 
examiners nor the support staff had knowl-
edge of the men’s semen quality.
Statistical analyses. Sperm concentration, 
total sperm count, and total motile count 
were logarithmically transformed to normalize 
their distributions. We examined possible drift 
in measurements by including exam date in 
multi  variate analyses both as a continuous and 
as a categorical variable. We assessed within-
observer variability in the AGD measure  ments 
by calculating the mean absolute difference 
in measurements. We used multiple regres-
sion analyses to identify predictors of each of 
the two AGD measurements. We then deter-
mined the relative importance of these pre-
dictors by examining the partial correlations 
between the measurement and the predictor, 
controlling for other variables in the model. 
We also used multiple regression analyses to 
examine associations between AGD measure-
ments and each semen parameter. Covariates 
initially examined, both as predictors of AGD 
measurements and as predictors of semen 
parameters, were ethnicity, height, body mass 
index (BMI), examiner, smoking status (cur-
rent smoker vs. not current smoker), exam 
date, testicular volume, and presence of tes-
ticular abnormalities (varico  cele and hydro-
cele). We also initially included a variable 
reflecting the number of stressful life events 
(Dohrenwend et al. 1978), previously shown 
to be significantly related to sperm count 
and motility (Gollenberg et al. 2010). When 
inclusion of a potential covariate resulted in 
a change in the β-coefficient of < 10%, the 
variable was not retained in final models. The 
exception was recruitment period, which was 
retained even though it had little effect on the 
regression coefficients for all sperm parameters. 
In addition, abstinence time was entered into 
all models predicting sperm concentration, 
volume, total sperm count, and total motile 
count, and time from sample collection to 
sample analysis was included in models pre-
dicting sperm motility and total motile count, 
because these variables are commonly con-
trolled in andrology research. In addition, we 
examined AGD in relation to the likelihood 
that a man’s sperm concentration fell below 
20 × 106/mL (WHO 1999) using logistic 
regression and controlling for the same covari-
ates. Final models are described in “Results.” 
Level of statistical significance was set at 0.05. 
Once models were determined, two analysts 
(J.M. and F.L.) conducted these analyses inde-
pendently using SAS (version 8; SAS Institute 
Inc., Cary, NC, USA) and SPSS (version 18.0; 
SPSS Inc., Chicago, IL, USA).
Results
The RYMS study population was quite homo-
geneous. Participants were 18–22 years of 
age (median age, 19.4 years), predominantly 
Caucasian (81%), non  smokers (73%), with 
a median BMI of 24.2. Median sperm con-
centration was 53.5 × 106/mL, and median 
total sperm count was 157 × 106. Demographic 
and reproductive parameters are summarized 
in Table 1. Although this was a population of 
apparently healthy young men, 24.6% of them 
had a sperm count < 20 × 106/mL, a commonly 
used cutoff for subfertility (WHO 1999).
The distributions of both AGDAS and 
AGDAP were approximately normal (Figure 2). 
AGDAS (mean, 51.3 mm; median, 51.7 mm) 
was, on average, 40% as long as AGDAP (mean, 
128 mm; median, 126 mm), and the SDs of 
these two measures were similar (14.5 mm 
Figure 1. Landmarks for two measurements 
of AGD: AGDAP, from the cephalad insertion 
of the penis to the center of the anus (point 1 
to point 3); and AGDAS, from the posterior base 
(first fold) of the scrotum to the center of the anus 
(point 2 to point 3). Adapted with permission from 
Sathyanarayana et al. (2010).
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and 13.0 mm for AGDAS and AGDAP, respec-
tively) (Table 1). As expected, AGDAS and 
AGDAP were highly correlated [Pearson cor-
relation (R) = 0.60, p < 0.0001].
Variability of AGD measurements. 
Variation with period of examination. Here we 
refer to fall 2009 as the first recruitment period 
and spring 2010 as the second recruitment 
period. We observed a small but significant 
decrease in both AGDAS and AGDAP between 
the first recruitment period (n = 44) and the 
second (n = 82). Mean AGDAS was 56.6 mm 
and 48.5 mm, and mean AGDAP was 132 mm 
and 126 mm, for men recruited during period 1 
and period 2, respectively. Mean age, BMI, 
abstinence time, and all semen parameters were 
similar in the two recruitment periods. Despite 
these differences between time periods, we 
saw no significant time trend within periods. 
Although neither exam date nor recruitment 
period was associated with any of the semen 
parameters (all p-values > 0.24), we retained 
recruitment period in all final models.
Within- and between-examiner variability. 
The mean (absolute) difference within examin-
ers was 1.39 mm for AGDAS (2.7% of mean 
AGDAS) and 2.62 mm for AGDAP (2.1% of 
mean AGDAP). We used a mixed model to 
estimate the inter  class correlations, which were 
0.91 [95% confidence interval (CI), 0.79–0.97] 
and 0.95 (95% CI, 0.89–0.98) for AGDAS and 
AGDAP, respectively. We repeated all regression 
analyses omitting the seven subjects measured 
by J. Stevens, and results were unchanged.
Predictors of AGDAS and AGDAP. We 
examined variables that predicted AGDAS 
and AGDAP (Table 2). BMI, height, and 
recruitment period (fall 2009 vs. spring 2010) 
were significant predictors of both meas  ures. 
Testicular volume, testicular abnormalities, 
stress, and ethnicity were not significantly 
related to AGD, so we did not retain them in 
the final models.
The model fit was better for predicting 
AGDAP than AGDAS (adjusted R2 = 0.45 and 
0.23, respectively). BMI accounted for most 
of the variability in AGDAP but little of the 
variability for AGDAS, whereas height was 
more influential for AGDAS.
AGD and other covariates in relation to 
semen parameters. Covariates retained in final 
models predicting semen parameters were 
AGD meas  ures, height, recruitment period, 
ethnicity (African American or not), absti-
nence time, and time to sample analysis as 
described in “Materials and Methods.”
AGDAS was positively related to sperm 
concentration, motility, morphology, total 
sperm count, and total motile count (p-values 
0.002, 0.028, 0.048, 0.006, and 0.009, respec-
tively; Table 3). The associations between 
AGDAP and sperm count and concentration 
were negligible, although in a similar direction 
as those for AGDAS. Regression coefficients for 
the two AGD meas  ures as predictors of sperm 
motility and morphology were not inconsis-
tent, although CIs for AGDAP were wider and 
consistent with no association. The residual 
plots for sperm concentration in relation to 
AGDAS and AGDAP from our multi  variate 
models, are shown in Figure 3.
We also examined sperm concentration 
dichotomized at 20 × 106/mL (subfertile vs. 
normal) in relation to AGD, controlling for 
the same covariates used in the linear regres-
sion models. AGDAS was significantly related 
to this outcome. The risk of subfertility was 
increased 7.3 times (95% CI, 2.5–21.6) for 
an (adjusted) AGDAS below the median, com-
pared with AGDAS above the median. Having 
a low sperm concentration (< 20 × 106/mL) 
was inversely related to AGDAS (p < 0.0019). 
AGDAP was not related to this outcome.
We calculated the expected change in 
semen parameters associated with an inter-
quartile increase in AGDAS for a typical study 
participant. When AGDAS is 43.1 mm, the 
25th percentile of the AGD distribution, the 
expected sperm concentration, using our final 
regression model, is 34.7 × 106/mL. When 
AGDAS is 61.1 mm (the 75th percentile), the 
expected sperm concentration is 51.6 × 106/
mL, whereas the predicted value for the 50th 
percentile of AGDAS is 42.0 × 106/mL. Thus, 
an interquartile increase in AGDAS is associ-
ated with an increase in sperm concentration 
Figure 2. Frequency distributions of AGDAS (A) and AGDAP (B) in our study population. 
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Table 1. Characteristics of RYMS participants (n = 126).
Variable Mean ± SD, or percent Median (IQR)
Age (years) 19.7 ± 1.0 19.4 (18.8–20.3)
BMI (kg/m2) 24.6 ± 3.5 24.2 (22.5–25.8)
Abstinence time (hr) 92.7 ± 78.3 70.7 (61.4–98.6)
Time to start semen analysis (min) 14.0 ± 7.1 10.0 (10.0–15.0)
Testicular volume (mL) 28.7 ± 4.9 26.9 (26.3–33.8)
AGD
AGDAS (mm) 51.3 ± 14.5 51.7 (43.1–61.1)
AGDAP (mm) 128 ± 13.0 126 (118–135)
Semen parameters
Seminal volume (mL) 3.3 ± 1.6 3.1 (2.1–4.3)
Sperm concentration (106/mL) 72.6 ± 66.5 53.5 (19.8–99.3)
Percent motile sperm (A + B)a 57.4 ± 15.5 60.3 (49.3–69.0)
Percent normal morphology (strict)b 8.4 ± 4.6 8.5 (5.0–12.4)
Total sperm count (106) 241 ± 269 157 (66.6–321)
Total motile count (106)a 143 ± 155 98.7 (30.5–197)
Ethnicity (%)
Caucasian 81.0
African-American 5.6
Other 13.4
Current smokers (%) 27.0
Varicocele present (%) 11.9
Abbreviations: IQR, interquartile range. 
aOne man with long time to analysis was excluded from motility analyses (n = 125). bTwo men with no morphology analy-
sis were excluded (n = 124). 
Table 2. Predictors of AGDAS and AGDAP in multivariate models.
AGDAS AGDAP
Variable β-Coefficient p-Value
R2 for single 
variable
Percent 
R2a β-Coefficient p-Value
R2 for single 
variable
Percent 
R2a
Height (cm) 0.76 < 0.0001 0.13 51.9% 0.59 < 0.0001 0.09 20.2%
BMI (kg/m2) 0.97 0.004 0.06 22.3% 2.18 < 0.0001 0.34 73.3%
Periodb –7.70 0.002 0.06 25.8% –4.75 0.01 0.03 6.5%
Adjusted R2 0.23 0.45
aR2 for single variable divided by adjusted R 2 for full model. bPeriod of study (fall 2009 vs. spring 2010).Anogenital distance and semen quality
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that is 40.2% of the median, based on the 
best-fitting model. Similar increases are 
seen for other sperm parameters, although a 
smaller increase is seen for percent morpho-
logically normal sperm.
Height, BMI, and time period were all 
associated with AGD and included in the 
final models, although none of these vari-
ables was associated with any semen param-
eter in this population. All sperm parameters 
were significantly lower in the small subgroup 
(n = 7) of African-American men compared 
with other men in this population (p-values 
for sperm parameters, < 0.001 to 0.016).
Discussion
This is the first study to measure AGD in adult 
men and examine the relationships between 
AGD measures and sperm parameters. We 
observed significant positive associations 
between AGDAS and sperm concentration, 
motility, morphology, total sperm count, 
and total motile count. The associations we 
observed between these sperm parameters 
and AGD were stronger than those for most 
covariates known to be associated with semen 
quality. For example, the increase in sperm 
concentration associated with an interquartile 
increase in AGDAS is twice as large as that 
expected in this population to be associated 
with an interquartile increase in abstinence 
time (8.4 × 106/mL), a known strong pre-
dictor of sperm concentration. Moreover, a 
man with an AGDAS below the median was 
7.3 times as likely to have a sperm concentra-
tion in the subfertile range (< 20 × 106/mL) as 
a man with an AGDAS above the median. This 
underscores the clinical implications of the 
associations that we are reporting.
AGD measurements were well tolerated by 
all subjects and quick to perform, with accept-
able intra  examiner reliability. Unlike ste-
roid hormones and semen parameters, AGD 
measurements are not likely to be sensitive 
to physiological and lifestyle factors (stress, 
abstinence time, fever, smoking, etc.) and so 
may need to be controlled only for body size, 
as was the case in our study. Therefore, if our 
results are confirmed, AGD may provide a 
useful adjunct to these traditional measures of 
male reproductive function.
Alternative measures of AGD. AGD has 
long been measured in animal studies, but the 
difference between AGDAS and AGDAP is not 
readily apparent in newborn pups, although it 
is clear in humans (Figure 1). AGD has only 
recently been measured in epidemiological 
studies, and methods for its reliable meas-
urement are still being developed. Several 
alternative measurements have been used 
in examining AGD in human male infants. 
Thankamony et al. (2009) and Salazar-
Martinez et al. (2004) used AGDAS, whereas 
Sathyanarayana et al. (2010)   meas  ured 
AGDAP. Romano-Riquer et al. (2007) used 
a third measure (posterior base of the penis to 
the anus), in addition to AGDAS and AGDAP. 
Torres-Sanchez et al. (2008) introduced a 
new measure (the distance from the tip of the 
coccyx to the center of the anus).
In our previous analyses we measured 
both AGDAS and AGDAP in human infants 
and related these to phthalate metabolites in 
maternal prenatal urine (Swan 2008; Swan 
et al. 2005). We found inverse associations 
that were, for most phthalate metabolites, 
stronger with AGDAP than with AGDAS. The 
distance covered by AGDAP is influenced by 
penile width and scrotal size as well as AGDAS 
(Figure 1). Penile width and testicular descent 
were themselves inversely associated with 
some phthalate concentrations in infants 
(Swan 2008), as they are in rodents (Barlow 
et al. 2004; Gray et al. 2006). Therefore, it is 
possible that the associations between infant 
AGD and phthalate metabolite concentrations 
are stronger for AGDAP than for AGDAS.
Because AGD varies with body size, this 
must be controlled in analysis. Methods for 
doing this have varied. The anogenital index 
(AGI; AGD divided by weight) was proposed 
by Vandenbergh and Huggett (1995) as a 
way to adjust AGD for body size in newborn 
mice. Since then, various functions of weight 
have been proposed in the calculation of this 
index, including cube root of weight (Gallavan 
et al. 1999) and weight at weaning (Hotchkiss 
et al. 2004). Swan et al. (2005) used AGI 
(AGD/weight at exam) at the mean age of 
12.8 months, but this method did not com-
pletely remove the effect of weight. Therefore, 
subsequent analysis (Swan 2008) used weight 
percentile for age (see Centers for Disease 
Control and Prevention 2010), a quantity that 
is largely independent of weight and age and 
that eliminates confounding by weight. Huang 
et al. (2009) used AGD, AGD ÷ birth weight, 
and AGD ÷ birth length. In RYMS men, we 
found that BMI and height were both signifi-
cantly associated with AGDAS and AGDAP, 
and we included both measures in our models 
predicting AGD.
In the present study, we examined men’s 
sperm parameters in relation to two variants 
of AGD: AGDAS and AGDAP. We saw sig-
nificant associations with sperm parameters 
only for AGDAS (Table 3, Figure 3). This may 
in part be due to the strong influence of BMI 
on adult AGDAP (Table 2), a quantity that 
influences the size of the fat pad anterior to 
the pubic symphysis, an area that is included 
in AGDAP but not in AGDAS. It may also be, 
however, that different AGD measurements 
better reflect androgen exposures at different 
life stages. Once a substantial body of norma-
tive data has been accumulated in infants and 
Figure 3. Partial regression plot (mean ± SE) of sperm concentration modeled as a function of (A) AGDAS 
and (B) AGDAP.
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Table 3. Multivariate analysis for men’s semen parameters and AGDAS and AGDAP.a
AGDAS AGDAP
Semen parameter β-Coefficient 95% CI p-Value β-Coefficient 95% CI p-Value
Seminal volume (mL) –0.002 –0.022 to 0.018 0.842 –0.010 –0.032 to 0.011 0.343
ln [sperm concentration 
(million/mL)]
0.022 0.008 to 0.036 0.002* 0.008 –0.007 to 0.023 0.290
Percent motile sperm (A + B)b,c 0.227 0.025 to 0.429 0.028* 0.161 –0.055 to 0.379 0.142
Percent morphologically normal 
spermd
0.061 0.0005 to 0.122 0.048* 0.051 –0.015 to 0.117 0.128
ln [total sperm count (million)] 0.021 0.006 to 0.037 0.006* 0.004 –0.012 to 0.021 0.596
ln [total motile sperm (million)]b,c 0.024 0.006 to 0.041 0.009* 0.009 –0.010 to 0.028 0.366
β-Coefficient indicates change in semen parameter associated with a 1 mm change in AGD.
aControlling for height, ethnicity (African American vs. not), period of study (fall 2009 vs. spring 2010), and ejaculation 
abstinence time. bAlso controlling for time from semen collection to start of semen analysis. c n = 125; one man with long 
time to analysis was excluded from motility analyses. dn = 124; two men without morphology were excluded. *p < 0.05. Mendiola et al.
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adults, it should be possible to identify the 
most androgen-sensitive measure (or meas  ures) 
and determine which are most strongly related 
to adult sexual function in adults. Until then, 
we suggest that future studies continue to col-
lect data on multiple measures.
Limitations. Our population was small 
and limited in age and ethnicity and thus 
cannot provide normative values for AGD 
measure  ments. We saw some differences in 
AGD and semen quality by race, but num-
bers were too small to study this adequately. 
Further, we obtained independent measure-
ments by two examiners on only eight men, 
too few to adequately estimate inter-rater reli-
ability. Additionally, we noted a small but 
systematic change in AGD measure  ments 
between fall 2009 and spring 2010. Although 
semen parameters in this population did not 
vary by study period and period did not con-
found our primary associations, these data 
suggest possible measure  ment drift and the 
need for on  going quality control, including 
frequent replicate measurements by indepen-
dent examiners throughout the course of any 
future study.
This is the first study in the United States 
to report on semen quality in young, unse-
lected men. We therefore cannot assess the rep-
resentativeness of our study population. There 
are, however, several studies in Europe that 
evaluated semen quality in men at the time of 
screening for military service (Jørgensen et al. 
2002). Median sperm concentration in our 
population was 53.5 × 106/mL, comparable 
to that seen in young men in these European 
countries (44–62 × 106/mL).
We measured testicular volume with a 
Prader orchidometer. We saw significant asso-
ciations between testicular volume and all 
semen parameters except motility, but not 
between testicular volume and either meas-
ure of AGD (data not shown). We could not 
determine whether this is a result of the rela-
tively coarse measure  ments available with the 
orchidometer or whether AGD is not cor-
related with testicular volume. The distribu-
tion of our testicular volume measurements 
appeared to suggest a tendency to report vol-
ume in whole numbers (digit preference) and 
was clearly not normally distributed. Possibly 
an ultra  sound measurement of testicular vol-
ume would answer this question.
Our study participants provided only 
a single semen sample. However, an earlier 
study of semen quality in 697 men, most of 
whom provided two samples, determined that 
after adjusting for important covariates, it 
made little difference in epidemiological stud-
ies whether the analysis includes men who 
give one semen sample or two (Stokes-Riner 
et al. 2007).
Finally, we plan to assess reproductive 
hormones in a future study. A finding of 
higher follicle-stimulating hormone and/or 
low inhibin-B or free testosterone in men with 
shorter AGD would lend support to the asso-
ciation between AGD and semen variables we 
report here.
Conclusions
Here we report data showing that one meas-
ure of AGD is strongly associated with mul-
tiple semen parameters, suggesting AGD’s 
potential use as a biomarker of develop  mental 
anti  androgen exposure. As animal studies 
(Welsh et al. 2008) have clearly shown, AGD 
is determined within a discrete masculiniza-
tion programming window that is determined 
by androgen action. Thus, the confirmation 
we present here is highly plausible, because, to 
date, all key relationships shown for AGD in 
the rat have also been shown in humans.
If AGD (adjusted for body size) is deter-
mined prenatally in humans as in rodents, a 
shorter AGD in adulthood should reflect a 
shorter AGD at birth, which in turn reflects 
decreased androgen exposure in utero. Thus, 
both poorer semen quality and shorter AGD 
in adulthood may reflect a common origin, 
including a disruption of testicular develop-
ment in utero, as suggested by the testicu-
lar dysgenesis syndrome (TDS) hypothesis 
(Skakkebaek et al. 2001). As hypothesized, 
this syndrome, although potentially multi-
factorial, may be caused by exposure to 
endocrine-  disrupting chemicals during the 
masculinization programming window 
(Scott et al. 2008). The increasing incidence 
of male reproductive dis  orders (Sharpe and 
Skakkebaek 2008; Skakkebaek et al. 2001; 
Toppari et al. 1996) and decreasing sperm 
counts and testosterone levels (Andersson et al. 
2007; Carlsen et al. 1992; Swan et al. 1997; 
Travison et al. 2007) in many Western coun-
tries lend support to this hypothesis. Whether 
shorter AGD in RYMS men reflects such dys-
genesis and whether this is a consequence of 
fetal anti  androgen exposure are speculative. 
However, the data we present here, together 
with our prior study relating shorter AGD to 
anti  androgenic phthalate exposure in infants, 
support that interpretation.
We suggest that a shortened male AGD 
may be an important marker of human TDS. 
An extended follow-up of a large cohort in 
which AGD is measured in infancy would 
be definitive, but logistically challenging. 
However, confirmation in larger and more 
diverse populations and in studies of AGD 
in men with clinical manifestations of TDS 
(infertile men, those born with cryptorchid-
ism or hypospadias, or men with testicular 
cancer) would provide persuasive evidence 
that androgen action during early fetal life 
exerts a fundamental influence on adult sperm 
counts in humans, as has been demonstrated 
in rodents.
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